Meta-analysis of 7 studies (1068 adults with B-ALL, 172 given blinatumomab): pretransplant blinatumomab vs chemotherapy had no significant effect on relapse (HR 0.67), survival or non-relapse mortality, with imprecise estimates; grade III-IV acute GVHD was lower (HR 0.50).
Meta-analysisn = 1,068
Rodriguez-Rodriguez et al. Impact of Pretransplant Blinatumomab on Post-Transplant Outcomes in B Cell Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis